Estimating outcomes and cost effectiveness using a single-arm clinical trial: ofatumumab for double-refractory chronic lymphocytic leukemia

Overview of attention for article published in Cost Effectiveness and Resource Allocation, May 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

blogs: 1 blog
policy: 1 policy source

twitter: 1 X user

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 26 Mendeley

Summary Blogs Policy documents X Dimensions citations

So far, Altmetric has seen 1 blog post.

Thesis Thursday: Anthony Hatswell

The Academic Health Economists' Blog, 15 Oct 2020

On the third Thursday of every month, we speak to a recent graduate about their thesis and their studies. This month’s guest is…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.